SCHEMBL20599745

SCHEMBL20599745

COC(=O)CCC1OCCC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.39
TDP1 Q9NUW8 3/20 0.36
SIRT2 Q8IXJ6 1/20 0.34
GLA P06280 1/20 0.34
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PTGER2 P43116 2/20 0.33
PTGER4 P35408 1/20 0.33
PTGER3 P43115 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
MEN1 O00255 1/20 0.32
PPARG P37231 2/20 0.32
NR2E3 Q9Y5X4 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4409031 0.84 LMNA (0.39) TSHRTDP1ALDH1A1KMT2ALMNA
SCHEMBL30510726 0.72 TSHR (0.50) TSHRSIRT2GLAALDH1A1KMT2A
SCHEMBL27324055 0.70 TSHR (0.43) TSHRTDP1ALDH1A1KMT2AMAPT
SCHEMBL10614279 0.69 TSHR (0.46) TSHRTDP1SIRT2ALDH1A1KMT2A
SCHEMBL9665578 0.69
SCHEMBL17407789 0.69
SCHEMBL11763977 0.68 NPC1 (0.54) TSHRTDP1ALDH1A1KMT2ALMNA
SCHEMBL9014001 0.68 TLR4 (0.45) TSHRTDP1ALDH1A1LMNAPTGER2
SCHEMBL30598229 0.68
SCHEMBL30598233 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3645516-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS Janssen Pharmaceutica NV (BE) 2020-05-06 EP disclosed
CN-110809574-A Heteroaryl dihydropyrimidine derivatives and methods for treating hepatitis b infection 詹森药业有限公司 2020-02-18 CN disclosed
WO-2019001420-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS JANSSEN PHARMACEUTICA NV (BE) 2019-01-03 WO disclosed